Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin
Dallman, P.R.
Advances in Pediatrics 40: 385-403
1993
ISSN/ISBN: 0065-3101 PMID: 8249712 Document Number: 408134
Document emailed within 1 workday
Related Documents
Wang, T.S.; Lee, C.C.; Deng, H.H.; Lin, J.T.; Chang, J.S.; Lin, S.T. 1995: The effect of recombinant human erythropoietin in treating the anemia of prematurity Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 36(2): 121-127Kumar, P.; Shankaran, S.; Krishnan, R.G. 1998: Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial Journal of Perinatology: Official Journal of the California Perinatal Association 18(3): 173-177
Pramatarova, T.; Yarakova, N.; Sluncheva, B.; Hitrova, S.; Radulova, P.; Emilova, Z. 2013: Blood transfusions suppress erythropoiesis in anemia of prematurity Akusherstvo i Ginekologiia 52(5): 42-46
Dyjas, R.; Wiecek, A.; Kokot, F. 1996: Treatment of non-renal anemia with human recombinant erythropoietin (rHU-EPO Przeglad Lekarski 53(6): 486-490
Avent, M.; Cory, B.J.; Galpin, J.; Ballot, D.E.; Cooper, P.A.; Sherman, G.; Davies, V.A. 2002: A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anaemia of prematurity in a developing country Journal of Tropical Pediatrics 48(4): 227-233
Valladares Ayerbes, M.J.; Valenzuela Claros, J.C.; Reina Zoilo, J.J.; Ruiz Borrego, M.; Moreno Nogueira, J.A. 1997: Human recombinant erythropoietin in the treatment of the anemia of multiple myeloma Anales de Medicina Interna 14(11): 593-594
Abels, R.I. 1992: Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer Seminars in Oncology 19(3 Suppl 8: 29-35
Henry, D.H. 1993: Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer Seminars in Hematology 30(4 Suppl 6: 12-16
Boratyńska, M.; Szewczyk, Z.; Szepietowski, T.; Czyz, W.; Cybulski, K.; Bogucki, J.; Szczepański, J. 1990: Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis Przeglad Lekarski 47(11): 741-745
Agroyannis, B.; Koutsicos, D.; Tzanatou-Exarchou, H.; Varsou-Papadimitriou, E.; Kapetanaki, A.; Yatzidis, H. 1991: Combined recombinant human erythropoietin-blood letting strategy for treating anemia and iron overload in hemodialysis patients International Journal of Artificial Organs 14(7): 403-406
Henry, D.H.; Beall, G.N.; Benson, C.A.; Carey, J.; Cone, L.A.; Eron, L.J.; Fiala, M.; Fischl, M.A.; Gabin, S.J.; Gottlieb, M.S. 1992: Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials Annals of Internal Medicine 117(9): 739-748
Karwacki, M.; Ochocka, M.; Kubiak, W. 1994: Anemia in AIDS: the problem to avoid. Human recombinant erythropoietin in the treatment of HIV positive patients Przeglad Epidemiologiczny 48(4): 441-447
Lastiri, Jé.M.; Specterman, S.R.; Rendo, P.; Pallotta, Mía.G.; Varela, M.S.; Goldstein, Sía. 2002: Predictive response variables to recombinant human erythropoietin treatment in patients with anemia and cancer Medicina 62(1): 41-47
Sulková, S.; Laurincová, Z.; Kvasnicka, J. 1990: Does aluminum affect the effectiveness of human recombinant erythropoietin in the treatment of anemia in dialyzed patients? Casopis Lekaru Ceskych 129(4): 113-115
Queipo Zaragozá, J.é A.; Chicote Pérez, F.; Beltrán Meseguer, J.F.; Borrell Palanca, A.; Giner Marco, V.; Esteve Claramunt, J.ús.; Pastor Sempere, F. 2004: Improvement of anemia and quality of life of patients with prostate cancer by treatment with human recombinant erythropoietin Archivos Espanoles de Urologia 57(1): 35-40
Stutz, B.; Rhyner, K.; Vögtli, J.; Binswanger, U. 1987: Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration Schweizerische Medizinische Wochenschrift 117(38): 1397-1402
Cannella, G.; Guerra, U.P.; Sandrini, M.; Gaggiotti, M.; Traverso, G.B.; Rolla, D.; Marsano, L.; Mulas, D. 1993: Changes in partition of extracellular fluid volumes in anemic dialyzed uremic patients after partial correction of the anemia with recombinant human erythropoietin treatment Clinical Nephrology 40(3): 164-167
Tsai, J.C.; Lai, Y.H.; Tsai, Z.Y.; Chien, L.J.; Tsai, J.H. 1991: Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum Gaoxiong Yi Xue Ke Xue Za Zhi 7(3): 126-135
Kulzer, P.; Schaefer, R.M.; Krahn, R.; Schaefer, L.; Heidland, A. 1994: Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group International Journal of Artificial Organs 17(4): 195-202
Jacquot, C.; Berthelot, J.M.; Chiappini-Judith, D.; Ferragu-Haguet, M.; Lefebvre, A.; Masselot, J.P.; Moynot, A.; Frydman, M.O.; Peterlongo, F. 1990: Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients Nephrologie 11(1): 11-16